Effect of Introducing Xpert MTB/RIF in Kazakhstan

A pilot study was conducted in Kazakhstan to assess the effects of introducing the Xpert MTB/RIF (Xpert) diagnostic test to detect tuberculosis (TB) and rifampicin resistant TB among individuals at risk of multidrug-resistant (MDR-)TB.

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us


De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.